Twist Bioscience (TWST) Research & Development (2017 - 2026)

Twist Bioscience (TWST) has reported Research & Development for 10 consecutive years, with $18.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development changed 0.12% year-over-year to $18.0 million in Q2 2026; TTM through Jun 2026 was $71.9 million, a 14.86% decrease from a year earlier, with the FY2025 full-year figure at $80.3 million, down 11.63% from the prior year.
• Research & Development was $18.0 million for Q2 2026 at Twist Bioscience, down from $19.7 million in the prior quarter.
• Over five years, Research & Development peaked at $36.8 million in Q2 2022 and troughed at $17.0 million in Q3 2025.
• A 5-year average of $23.9 million and a median of $23.4 million in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development surged 97.78% in 2022 and sank 33.42% in 2023, its largest moves.
• Over 5 years, Research & Development stood at $31.2 million in 2022, then fell by 26.06% to $23.1 million in 2023, then fell by 7.76% to $21.3 million in 2024, then decreased by 19.6% to $17.1 million in 2025, then climbed by 5.22% to $18.0 million in 2026.
• The last three Research & Development figures came in at $18.0 million (Q2 2026), $19.7 million (Q1 2026), and $17.1 million (Q4 2025), per Business Quant data.